Patent drug costs come under scrutiny as China looks to improve HIV treatment
This article was originally published in Scrip
Executive Summary
Spurred by the number of HIV carriers and AIDS patients in the country topping an estimated 780,000 by the end of 2011, China is to invest Yuan70 billion ($11 billion) by 2015 in the control of the disease, according to a new five-year plan released by the central government.